Modeling of this subtype of GBM has been achieved in adult mice by adenoviral Cre delivery to the striatum to activate expression of EGFR (both WT and VIII) with simultaneous inactivation of PTEN and INK4A/ARF[15]. This evidence concerns the gene PTEN and glioblastoma.